Safety of a mRNA COVID-19 Vaccine in Patients with Indolent Systemic Mastocytosis

Acta Med Port. 2024 Mar 1;37(3):224-225. doi: 10.20344/amp.20851. Epub 2024 Mar 1.
No abstract available

Keywords: COVID-19/immunology; COVID-19 Vaccines; Mastocytosis; Messenger; RNA; Systemic/immunology.

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines* / administration & dosage
  • COVID-19* / prevention & control
  • Humans
  • Mastocytosis, Systemic* / complications

Substances

  • COVID-19 Vaccines